Yahoo Finance Have Insiders Sold PetMed Express, Inc. (NASDAQ:PETS) Shares Recently?
We'd be surprised if PetMed Express, Inc. (NASDAQ:PETS) shareholders haven't noticed that the Independent Director, Gian Fulgoni, recently sold US$317k worth of stock at US$26.45 per share. That sale was 17% of their holding, so it does make us raise an eyebrow.
Check out our latest analysis for PetMed Express
The Last 12 Months Of Insider Transactions At PetMed Express
In fact, the recent sale by Gian Fulgoni was the biggest sale of PetMed Express shares made by an insider individual in the last twelve months, according to our records. So we know that an insider sold shares at around the present share price of US$25.81. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.
You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
I will like PetMed Express better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
Does PetMed Express Boast High Insider Ownership?
For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 4.4% of PetMed Express shares, worth about US$23m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
So What Do The PetMed Express Insider Transactions Indicate?
An insider hasn't bought PetMed Express stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. Insiders own shares, but we're still pretty cautious, given the history of sales. We're in no rush to buy! Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for PetMed Express.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
